CEACAM6
Cell adhesion molecule CEACAM6
Also known as: CD66c, CEAM6_HUMAN, NCA
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P40199
- Gene
- CEACAM6
- Ensembl
- ENSG00000086548
- Chromosome
- 19
- Canonical length
- 344 aa
- Protein class
- Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a protein that belongs to the carcinoembryonic antigen (CEA) family whose members are glycosyl phosphatidyl inositol (GPI) anchored cell surface glycoproteins. Members of this family play a role in cell adhesion and are widely used as tumor markers in serum immunoassay determinations of carcinoma. This gene affects the sensitivity of tumor cells to adenovirus infection. The protein encoded by this gene acts as a receptor for adherent-invasive E. coli adhesion to the surface of ileal epithelial cells in patients with Crohn's disease. This gene is clustered with genes and pseudogenes of the cell adhesion molecules subgroup of the CEA family on chromosome 19. [provided by RefSeq, Apr 2014]
Canonical amino-acid sequenceUniProt
344 residues, UniProt reviewed canonical sequence.
>P40199|CEACAM6
1 MGPPSAPPCR LHVPWKEVLL TASLLTFWNP PTTAKLTIES TPFNVAEGKE VLLLAHNLPQ
61 NRIGYSWYKG ERVDGNSLIV GYVIGTQQAT PGPAYSGRET IYPNASLLIQ NVTQNDTGFY
121 TLQVIKSDLV NEEATGQFHV YPELPKPSIS SNNSNPVEDK DAVAFTCEPE VQNTTYLWWV
181 NGQSLPVSPR LQLSNGNMTL TLLSVKRNDA GSYECEIQNP ASANRSDPVT LNVLYGPDVP
241 TISPSKANYR PGENLNLSCH AASNPPAQYS WFINGTFQQS TQELFIPNIT VNNSGSYMCQ
301 AHNSATGLNR TTVTMITVSG SAPVLSAVAT VGITIGVLAR VALILocalizationUniProt · AlphaFold · HPA
Whether an antibody against CEACAM6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 270 nTPM
Expression across tissuesHPA
Tissue
- lung: 270 nTPM
- rectum: 207 nTPM
- esophagus: 195 nTPM
- colon: 183 nTPM
- salivary gland: 178 nTPM
- bone marrow: 171 nTPM
Single-cell type
- esophageal apical cells: 2,066 nCPM
- alveolar cells type 1: 1,945 nCPM
- transitional alveolar cells: 847 nCPM
- colonocytes: 473 nCPM
- respiratory deuterosomal cells: 465 nCPM
- respiratory secretory cells: 449 nCPM
Immune cell
- total PBMC: 3.1 nTPM
- neutrophil: 1.1 nTPM
- naive B-cell: 0.6 nTPM
- non-classical monocyte: 0.6 nTPM
- intermediate monocyte: 0.5 nTPM
- classical monocyte: 0.1 nTPM
Brain region
- basal ganglia: 4.6 nTPM
- cerebellum: 3.3 nTPM
- cerebral cortex: 3.1 nTPM
- white matter: 2.9 nTPM
- medulla oblongata: 2.7 nTPM
- amygdala: 2.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.22
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.19
- DepMap mean gene effect
- -0.22
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules
- homophilic cell adhesion via plasma membrane adhesion molecules
- negative regulation of anoikis
- positive regulation of cell migration
- positive regulation of cell population proliferation
- positive regulation of endothelial cell-matrix adhesion via fibronectin
- positive regulation of heterotypic cell-cell adhesion
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CEACAM6 as an antibody target. Whether an autoantibody or antibody against CEACAM6 could matter depends on whether native CEACAM6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CEACAM6 is annotated at the cell surface, where native CEACAM6 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CEACAM6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...